Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma
Authors
Keywords
HGFK1, Sorafenib, Renal cell carcinoma, Autophagy, Cancer stem cell
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-19
DOI
10.1186/s13046-019-1348-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma
- (2018) Wenyan Zhang et al. BRITISH JOURNAL OF CANCER
- Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT
- (2018) Jie Mao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- HGF/c-MET Signaling in Melanocytes and Melanoma
- (2018) Malgorzata Czyz INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer
- (2016) Sameerah Shaheen et al. Stem Cell Reviews and Reports
- Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin
- (2016) Hong-Wu Xin et al. Journal of Cancer
- Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer
- (2016) Sameerah Shaheen et al. Stem Cell Reviews and Reports
- Mechanisms of Autophagy
- (2015) Nobuo N. Noda et al. Annual Review of Biophysics
- The Adverse Effects of Sorafenib in Patients with Advanced Cancers
- (2015) Ye Li et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- The role for autophagy in cancer
- (2015) Eileen White JOURNAL OF CLINICAL INVESTIGATION
- Autophagy in cellular metabolism and cancer
- (2015) Xuejun Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine
- (2015) Ming-Chen Yang et al. Molecular Cancer
- Suppression of cancer relapse and metastasis by inhibiting cancer stemness
- (2015) Youzhi Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)
- (2014) Zofia Bielecka et al. Current Signal Transduction Therapy
- Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib
- (2014) Hongming Pan et al. Scientific Reports
- Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance
- (2013) Wen Yue et al. Autophagy
- Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
- (2013) L. Goyal et al. CLINICAL CANCER RESEARCH
- Label-retaining liver cancer cells are relatively resistant to sorafenib
- (2013) Hong-Wu Xin et al. GUT
- Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?
- (2013) Carmen Berasain GUT
- Autophagy in Human Health and Disease
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Combination Therapy in Metastatic Renal Cell Cancer
- (2013) Alain Ravaud et al. SEMINARS IN ONCOLOGY
- Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
- (2012) S Hagiwara et al. BRITISH JOURNAL OF CANCER
- HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway
- (2012) Y Yao et al. CANCER GENE THERAPY
- Induction of cancer cell stemness by chemotherapy
- (2012) Xingwang Hu et al. CELL CYCLE
- EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis
- (2012) Y. Feng et al. CELL PROLIFERATION
- Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
- (2012) Marie-José Blivet-Van Eggelpoël et al. JOURNAL OF HEPATOLOGY
- A Detailed Mammosphere Assay Protocol for the Quantification of Breast Stem Cell Activity
- (2012) Frances L. Shaw et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
- (2011) Piyush B. Gupta et al. CELL
- Effective Melanoma Immunotherapy with Interleukin-2 Delivered by a Novel Polymeric Nanoparticle
- (2011) H. Yao et al. MOLECULAR CANCER THERAPEUTICS
- NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
- (2011) C R Jeter et al. ONCOGENE
- Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Clinical Evidence
- (2011) T. E. Hutson ONCOLOGIST
- An overview of the c-MET signaling pathway
- (2011) Shawna Leslie Organ et al. Therapeutic Advances in Medical Oncology
- Mechanical and structural properties of YOYO-1 complexed DNA
- (2010) K. Gunther et al. NUCLEIC ACIDS RESEARCH
- The gene transfection efficiency of a folate–PEI600–cyclodextrin nanopolymer
- (2009) Hong Yao et al. BIOMATERIALS
- NF-κB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy
- (2009) Jian-Min Wu et al. CANCER LETTERS
- Resistance to targeted therapy in renal-cell carcinoma
- (2009) Brian I Rini et al. LANCET ONCOLOGY
- A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma
- (2008) Zan Shen et al. CANCER LETTERS
- The Kringle 1 Domain of Hepatocyte Growth Factor Has Antiangiogenic and Antitumor Cell Effects on Hepatocellular Carcinoma
- (2008) Z. Shen et al. CANCER RESEARCH
- AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer
- (2008) B. Nie et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation